The USSONAR Ultrasound-Guided Synovial Biopsy Training Program is a one to two-day course intended for rheumatologists. The purpose of the course is to provide familiarization with and basic instruction in the procedures necessary to obtain synovial tissue for both research and clinical purposes.

We welcome your interest in participating in this course. As the content requires mastery of basic musculoskeletal ultrasound knowledge and skills, we do ask that as a prerequisite that participants have proof of certification and knowledge/skills in basic musculoskeletal ultrasound. This will be asked for as part of the registration process. We wish to ensure that this is provided as the procedure being taught is invasive in nature, and we want to ensure not only the safety of participants and faculty during the course but also prospective patients undergoing synovial biopsy.

Space is limited and subject to approval. 

Upcoming Courses:

• Jan 21-22, 2023 in Loma Linda, CA       Completed
• May 20, 2023 in Tampa, FL                     Learn more and register here   
• May 2024 in Tampa, FL                           Details Pending

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida AHEC Network and USSONAR. The Florida AHEC Network is accredited by the Florida Medical Association to provide continuing medical education to physicians.

The Florida AHEC Network designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                                   

Financial Disclosures:

• USSONAR acknowledges Exagen Inc. for their commercial support of this educational activity.
• Ultrasound Equipment systems will be provided by Esaote North America as in-kind donations.
• Dr. Ami Ben-Artzi, Dr. Diane Lewis Horowitz, and Dr. Darren Tabechian have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Dr. Arthur M Mandelin II is a Consultant for CVS CareMark and serves on the Speakers’ Bureau for Abbott/AbbVie, Bristol Myers Squibb, Horizon, Lily, Pfizer, and Sanofi-Genzyme/Regeneron.